What is GTLB's health score?

Gitlab Inc. (GTLB) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GTLB's estimated fair value?

Based on our 5-year discounted cash flow model, Gitlab Inc.'s estimated fair value is $12.32 per share, representing a -60.0% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GTLB undervalued or overvalued?

Our model currently rates GTLB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for GTLB... Refresh in a moment for the full analysis.

Gitlab Inc. (GTLB)

Technology Overvalued low mixed

$30.84

Updated: 2026-06-04

TradeApes Score

Financial Strength

40 Weak

Operating Trend

73 Healthy

Relative Value

55 Mixed

Capital Allocation

25 Stressed

Risk

70 Healthy

Est. Fair Value $12.32

DCF Upside -60.0%

Sector Rank #734 of 7825

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.